Selective inhibitors of neurotensin degrading enzymes

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

12000273

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Embodiments of this invention relate to compounds that are selective inhibitors of neurotensin degrading enzymes, to pharmaceutical compositions containing these compounds, to methods for preparing these compounds, methods for preparing novel intermediates useful for the synthesis of these compounds, and methods for preparing compositions containing these compounds. The invention also relates to the use of such compounds and compositions for regulating blood pressure or gastric emptying, or treating Parkinson's disease, anxiety, depression, or psychosis. The compounds have the formula (1) wherein the symbols have the meanings given in the specification.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SOLVAY PHARMACEUTICALS B VC J VAN HOUTENLAAN 36 NL-1381 CP WEESP

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Feenstra, Roelof W Weesp, NL 16 62
Kruse, Cornelis G Weesp, NL 66 310
Smid, Pieter Weesp, NL 10 17

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation